Bentham Science Logo

Track Your Manuscript:


Endocrine, Metabolic & Immune Disorders - Drug Targets

Formerly: Current Drug Targets - Immune, Endocrine & Metabolic Disorders

Volume 20, 10 Issues, 2020
ISSN: 2212-3873 (Online)
ISSN: 1871-5303 (Print)
This journal supports open access

In the current pandemic scenario, publication process of all articles related to Coronavirus will be expedited, for timely publication of much needed research

Contents

Endocrine, Metabolic & Immune Disorders - Drug Targets, Volume 8 - Number 1




The HIV-1 Rev Binding Family of Proteins: The Dog Proteins as a Study Model

, 8(1): 30 - 46

Maria A. Panaro, Vincenzo Mitolo, Antonia Cianciulli, Pasqua Cavallo, Carlo I. Mitolo and Angela Acquafredda


DOI: 10.2174/187153008783928325





Epithelial-Mesenchymal Transition as a Therapeutic Target for Prevention of Ocular Tissue Fibrosis

, 8(1): 69 - 76

Shizuya Saika, Osamu Yamanaka, Kathleen C. Flanders, Yuka Okada, Takeshi Miyamoto, Takayoshi Sumioka, Kumi Shirai, Ai Kitano, Ken-ichi Miyazaki, Sai-ichi Tanaka and Kazuo Ikeda


DOI: 10.2174/187153008783928343



Editor-in-Chief

Emilio Jirillo
Department of Basic Medical Sciences Neuroscience and Sensory Organs
University of Bari “Aldo Moro”
Bari
(Italy)
Biography
View Full Editorial Board

COPE Compliant

Journal History

Current Drug Targets - Immune, Endocrine & Metabolic Disorders was launched in 2001 and later renamed in 2006 as Endocrine, Metabolic & Immune Disorders - Drug Targets.
Scopus CiteScore Metrics: 1.79

Society Accreditations



Society Name: The official Journal of Associazione Medici Endocrinologi


Advertisement

Covid Resource Center

Related Journals

Related eBooks

eBooks Catalog